4973.T JPX
Japan Pure Chemical Co.,Ltd.
1W: -0.3%
1M: -1.9%
3M: -9.4%
YTD: -2.5%
1Y: +54.8%
3Y: +107.7%
5Y: +87.0%
¥5,100.00 ($32.33)
+325.00 (+6.81%)
Weekly Expected Move ±3.0%
¥4489
¥4632
¥4775
¥4918
¥5061
Overview
Chart
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Analysis
Technicals
Weather
Peers
Balance Sheet Trends
Total Assets
$15.9B
-7.5% ▼
5Y CAGR: +4.6%
Total Liabilities
$2.3B
-13.1% ▼
5Y CAGR: +3.6%
Shareholders Equity
$13.6B
-6.5% ▼
5Y CAGR: +4.8%
Cash & Investments
$7.6B
+23.1% ▲
5Y CAGR: +11.0%
Total Debt
$0
+0.0% ▲
Net Debt
-$7.6B
-29.5% ▼
Assets vs Liabilities & Equity
Year-over-Year Growth
View Full Balance Sheet
| Line Item | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 |
|---|---|---|---|---|---|
| — Assets — | |||||
| Cash | $4.4B | $4.0B | $5.8B | $5.9B | $7.6B |
| Short-Term Investments | $0 | $0 | $0 | $301M | $0 |
| Cash & ST Investments | $4.4B | $4.0B | $5.8B | $6.2B | $7.6B |
| Net Receivables | $2.6B | $3.4B | $1.6B | $1.5B | $1.4B |
| Inventory | $788M | $846M | $432M | $333M | $548M |
| Other Current Assets | $320M | $8M | $23M | $5M | $2M |
| Total Current Assets | $8.1B | $8.3B | $7.8B | $8.0B | $9.5B |
| Property, Plant & Equip. | $210M | $123M | $87M | $160M | $114M |
| Goodwill & Intangibles | $76M | $49M | $14M | $89M | $132M |
| Long-Term Investments | $7.7B | $8.3B | $7.6B | $8.8B | $6.0B |
| Other Non-Current Assets | $47M | $52M | $98M | $92M | $91M |
| Total Non-Current Assets | $8.1B | $8.6B | $7.8B | $9.1B | $6.3B |
| Total Assets | $16.1B | $16.9B | $15.6B | $17.1B | $15.9B |
| — Liabilities — | |||||
| Accounts Payable | $709M | $220M | $46M | $29M | $76M |
| Short-Term Debt | $0 | $0 | $0 | $0 | $0 |
| Deferred Revenue | $0 | $0 | $0 | $0 | $0 |
| Other Current Liabilities | $95M | $64M | $125M | $152M | $95M |
| Total Current Liabilities | $1.0B | $551M | $238M | $334M | $785M |
| Long-Term Debt | $0 | $0 | $0 | $0 | $0 |
| Other Non-Current Liab. | $221M | $221M | $221M | $221M | $222M |
| Total Non-Current Liabilities | $1.9B | $2.1B | $1.9B | $2.3B | $1.5B |
| Total Liabilities | $2.9B | $2.6B | $2.1B | $2.6B | $2.3B |
| — Equity — | |||||
| Common Stock | $1.3B | $1.3B | $1.3B | $1.3B | $1.3B |
| Retained Earnings | $3.0B | $3.5B | $2.9B | $3.0B | $3.9B |
| Accumulated OCI | $9.2B | $9.5B | $9.0B | $5.0B | $3.2B |
| Total Stockholders Equity | $13.2B | $14.2B | $13.5B | $14.5B | $13.6B |
| Total Liabilities & Equity | $16.1B | $16.9B | $15.6B | $17.1B | $15.9B |
| — Key Metrics — | |||||
| Total Debt | $0 | $0 | $0 | $0 | $0 |
| Net Debt | -$4.4B | -$4.0B | -$5.8B | -$5.9B | -$7.6B |
| Total Investments | $7.7B | $8.3B | $7.6B | $9.1B | $6.0B |